Methotrexate and histologic hepatic abnormalities: a meta-analysis.

[1]  H. Roenigk,et al.  Hepatotoxicity of methotrexate in the treatment of psoriasis. , 1971, Archives of dermatology.

[2]  H. Maibach,et al.  Methotrexate guidelines--revised. , 1982, Journal of the American Academy of Dermatology.

[3]  Willkens Rf,et al.  Low dose pulse methotrexate therapy in rheumatoid arthritis. , 1980 .

[4]  H. Zachariae,et al.  Methotrexate-induced liver cirrhosis. A follow-up. , 1987, Dermatologica.

[5]  M. Weinblatt,et al.  The liver in rheumatic diseases. , 1982, Seminars in arthritis and rheumatism.

[6]  R. E. Small,et al.  Low‐dose methotrexate compared with auranofin in adult rheumatoid arthritis , 1990 .

[7]  K. Kragballe,et al.  Methotrexate induced liver cirrhosis , 1980, The British journal of dermatology.

[8]  M. Colombo,et al.  Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. , 1986, Journal of hepatology.

[9]  R T Hoffmeister,et al.  Methotrexate therapy in rheumatoid arthritis: 15 years experience. , 1983, The American journal of medicine.

[10]  D. Pisetsky,et al.  Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis. , 1988, The American journal of medicine.

[11]  K. Tolman,et al.  Methotrexate and the liver. , 1985, The Journal of rheumatology. Supplement.

[12]  J. Kremer,et al.  The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. , 1986, Arthritis and rheumatism.

[13]  J. M. Kremer,et al.  Methotrexate in rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[14]  A. Nyfors.  Liver biopsies from psoriatics related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics. , 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[15]  A. H. Mackenzie.  Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis. , 1985, Cleveland Clinic quarterly.

[16]  D. Lowe,et al.  Magnetic resonance imaging as a screening procedure for methotrexate induced liver damage , 1987, The British journal of dermatology.

[17]  R. Gubner,et al.  THERAPEUTIC SUPPRESSION OF TISSUE REACTIVITY: II. Effect of Aminopterin in Rheumatoid Arthritis and Psoriasis , 1951, The American journal of the medical sciences.

[18]  R. Auerbach,et al.  Methotrexate hepatotoxicity in psoriasis. Consideration of liver biopsies at regular intervals. , 1980, Archives of dermatology.

[19]  M. Weinblatt,et al.  Efficacy of low-dose methotrexate in rheumatoid arthritis. , 1985, The New England journal of medicine.

[20]  E. Hersh,et al.  Hepatotoxic effects of methotrexate , 1966, Cancer.

[21]  H. Maibach,et al.  Liver disease in psoriatics--An effect of methotrexate therapy? , 1974, Archives of dermatology.

[22]  T. Taylor,et al.  Low dose oral methotrexate in rheumatoid arthritis: an uncontrolled trial and review of the literature. , 1983, Seminars in arthritis and rheumatism.

[23]  J. Haserick,et al.  Methotrexate for psoriasis. A preliminary report. , 1965, Cleveland Clinic quarterly.

[24]  G. Alarcón,et al.  Methotrexate-induced liver abnormalities in rheumatoid arthritis. , 1989, The Journal of rheumatology.

[25]  H. R. Vickers,et al.  Methotrexate hepatotoxicity in psoriasis. , 1972, British medical journal.

[26]  Rowland W. Chang,et al.  The diagnosis of polyarteritis nodosa , 1988 .

[27]  M. Weinblatt,et al.  Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[28]  R. Ashton,et al.  Complications in methotrexate treatment of psoriasis with particular reference to liver fibrosis. , 1982, The Journal of investigative dermatology.

[29]  J. Kremer,et al.  Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples. , 1989, Arthritis and rheumatism.

[30]  H. Frenzel,et al.  Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate. , 1989, The Journal of rheumatology.

[31]  M. Petrelli,et al.  Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate. , 1988, Arthritis and rheumatism.

[32]  M D Silverstein,et al.  The diagnosis of polyarteritis nodosa. I. A literature-based decision analysis approach. , 1988, Arthritis and rheumatism.

[33]  L. Moreland,et al.  Prospective analysis of liver biopsies before and after methotrexate therapy in rheumatoid patients. , 1989, Seminars in arthritis and rheumatism.

[34]  B. Sandstedt,et al.  Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis. , 1987, Scandinavian journal of rheumatology.

[35]  J. Lifson,et al.  Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study. , 1985, Annals of internal medicine.